ABOUT RENTSCHLER BIOPHARMA
Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, along with related consulting services, project management, and regulatory support. Its long-standing experience and commitment to quality are supported by a robust quality management system, operational excellence, and advanced technologies across all development and manufacturing stages. Rentschler Biopharma is a family-owned company with approximately 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. In 2024, the company joined the United Nations Global Compact, reinforcing its commitment to sustainability.
INDUSTRY INSIGHTS
-
Learn how bioreactor modeling can reduce scale-up and transfer risk by creating more representative downscale models for process characterization, troubleshooting and manufacturing transfers, including an example comparing traditional scale-down methods with a shear stress-based approach.
-
See how a cell culture process scaled across two manufacturing sites while maintaining comparable performance and product quality amid changing requirements
-
Explore how power input, tip speed, mixing, oxygen transfer, sparger geometry and shear forces change with scale, and why equipment knowledge and process experience are critical to informed scale-up decisions.
-
Learn how focused optimization and coordinated execution helped overcome technical uncertainty and enable faster progression to market readiness.
-
Flexible development and manufacturing are essential for complex biologics. See scalable processes, advanced cell line strategies, and partnership models that move programs efficiently.
-
Complex biologics require flexible development, advanced analytics, and quality by design. Learn how collaborative bioprocessing reduces risk, enables efficient scaleāup, and supports clinical success.
-
Data-driven virus clearance improves risk assessment, process insight, and study design. Learn how Quality by Design cuts late-stage risk while strengthening regulatory confidence and viral safety.
-
Technology transfer succeeds through trust, shared knowledge, and disciplined execution. See how collaboration, strong documentation, and digital tools reduce risk on the path to GMP.
CONTACT INFORMATION
Rentschler Biopharma
Erwin-Rentschler-Straße 21
Laupheim, D-88471
GERMANY
Phone: +49 7392 701-874
SOLUTIONS
-
At Rentschler Biopharma, we help biopharma innovators advance complex large molecule programs from development through commercial manufacturing.
-
Next-gen CMC uses high-performing cell lines to accelerate timelines, improve consistency, and scale efficiently, leveraging gains in stability, pool quality, and process intensification.
-
Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects.
-
Scientific innovation alone isn’t enough. Success requires smart development, adaptable strategies, and partners who manage pressure, supply risk, and tight timelines — while keeping quality central.